Bioprocessing Breakthrough: Xheme non-Toxic, multifunctional additive eliminates oxidative stress

Abstract

Oxidative stress—an imbalance of free radicals and antioxidants—regularly reduces the yield of pharmaceuticals and therapeutics produced via bioprocessing by about 10-15%. On July 21, 2023, Xheme announced that the Xheme Multifunctional Additive (XMA), a programmable non-toxic nanoporous microparticle, has reportedly demonstrated the ability to significantly reduce or eliminate the damage of oxidative stress in bioprocessing conditions.